Summary
Lyme disease (LD), also known as Lyme borreliosis and carried by Ixodes ticks, is the most common zoonotic disease in the northern hemisphere. Although the prevalence of the disease in Turkey is not known exactly, seroepidemiologic studies show that the prevelance ranges between 2-44%. Case reports suggest that our country is endemic for Lyme. In addition, a recent study showed that Borrelia burgdorferi (B. burgdorferi) sensu stricto, Borrelia garinii, Borrelia afzelii, Borrelia lusitania and Borrelia valaisiana from B. burgdorferi sensu lato group of species were found in Ixodes ricinus in the Thrace region of Turkey. In untreated patients, the disease process can be seen in three phases. Erythema migrans (EM) and flu-like illness may be seen in the first phase. EM migrans lesions, joint, nervous system, eyes, and heart involvement may develop 3-10 weeks after receipt of the pathogen in the second phase. Last stage is after months or years. Joint and neurological involvements are prominent in the absence of EM lesions in almost 11% of patients. The duration and choice of antibiotic treatment may vary according to the severity of organ involvement and disease. Anti-inflammatory drug treatment is also as important as antibiotics. Different clinical courses in which EM are not found can cause diagnostic difficulties and untreated disease. Even in the absence of a history of tick bite, LD should be considered in the differential diagnosis. Early diagnosis and initiation of antibiotic treatment are of importance. Determining endemic regions and enhancing knowledge of the disease among physicians and society are needed for early diagnosis, treatment, and control of Lyme disease.
Keywords:
Borrelia burgdorferi, Ixodes, Lyme disease, ticks, Turkey
References
1
Schotthoefer AM, Frost HM. Ecology and Epidemiology of Lyme Borreliosis. Clin Lab Med. 2015;35:723-43.
2
Borchers AT, Keen CL, Huntley AC, Gershwin ME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82-115.
3
Sanchez JL. Clinical Manifestations and Treatment of Lyme Disease. Clin Lab Med. 2015;35:765-78.
4
Tilly K, Rosa PA, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am. 2008;22:217-34, v.
5
Polat E, Turhan V, Aslan M, Musellim B, Onem Y, Ertugrul B. [First report of three culture confirmed human Lyme cases in Turkey]. Mikrobiyol Bul. 2010;44:133-9.
6
Guner ES, Hashimoto N, Takada N, Kaneda K, Imai Y, Masuzawa T. First isolation and characterization of Borrelia burgdorferi sensu lato strains from Ixodes ricinus ticks in Turkey. J Med Microbiol. 2003;52:807-13.
7
Pritt BS, Mead PS, Johnson DK, Neitzel DF, Respicio-Kingry LB, Davis JP, Schiffman E, Sloan LM, Schriefer ME, Replogle AJ, Paskewitz SM, Ray JA, Bjork J, Steward CR, Deedon A, Lee X, Kingry LC, Miller TK, Feist MA, Theel ES, Patel R, Irish CL, Petersen JM. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016;16:556-64.
8
Herrmann C, Gern L. Search for blood or water is influenced by Borrelia burgdorferi in Ixodes ricinus. Parasit Vectors. 2015;8:6.
9
CDC. Lyme disease data tables 2016 [21.04.2016]. Available from: http:// www.cdc.gov/lyme/stats/tables.html.
10
Ozdemir D, İnce N. Lyme Disease. J Microbiol Infect Dis. 2014;(Suppl 1):S32-S40.
11
Yemişen M, Mete B, Balkan İİ. Lyme hastalığı. J Exp Clin Med. 2012:169-74.
12
Anlar FY, Durlu Y, Aktan G, Acikgoz E, Bingol N, Madencioglu V, Anlar B. [Clinical characteristics of Lyme disease in 12 cases]. Mikrobiyol Bul. 2003;37:255-9.
13
Guner ES, Hashimoto N, Kadosaka T, Imai Y, Masuzawa T. A novel, fastgrowing Borrelia spp. isolated from the hard tick Hyalomma aegyptium in Turkey. Microbiology. 2003;149:2539-44.
14
Kaygusuz I, Godekmerdan A, Karlidag T, Keles E, Yalcin S, Tazegul A. [An investigation of patients with acute peripheral facial palsy with regard to Lyme disease]. Kulak Burun Bogaz Ihtis Derg. 2003;10:143-7.
15
Guner ES, Watanabe M, Kadosaka T, Polat E, Gargili A, Gulanber A, Ohashi N, Kaneda K, Imai Y, Masuzawa T. Seroepidemiology of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in wild mice captured in northern Turkey. Epidemiol Infect. 2005;133:331-6.
16
Gunes T, Poyraz O, Kaya S, Gencer L, Alim A. [Investigation of vectors for Borrelia burgdorferi and Lyme seropositivity in Sivas region]. Mikrobiyol Bul. 2005;39:503-8.
17
Bhide M, Yilmaz Z, Golcu E, Torun S, Mikula I. Seroprevalence of anti- Borrelia burgdorferi antibodies in dogs and horses in Turkey. Ann Agric Environ Med. 2008;15:85-90.
18
Kaya AD, Parlak AH, Ozturk CE, Behcet M. Seroprevalence of Borrelia burgdorferi infection among forestry workers and farmers in Duzce, northwestern Turkey. New Microbiol. 2008;31:203-9.
19
Sen E, Uchishima Y, Okamoto Y, Fukui T, Kadosaka T, Ohashi N, Masuzawa T. Molecular detection of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes ricinus ticks from Istanbul metropolitan area and rural Trakya (Thrace) region of north-western Turkey. Ticks Tick Borne Dis. 2011;2:94-8.
20
Aslan Basbulut E, Gozalan A, Sonmez C, Coplu N, Korhasan B, Esen B, Akin L, Ertek M. [Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey]. Mikrobiyol Bul. 2012;46:247-56.
21
Parlak M, Bayram Y, Cikman A, Ceylan N, Berktas M. [Seropositivity of Borrelia burgdorferi in risky groups in Van region, Turkey]. Mikrobiyol Bul. 2015;49:439-45.
22
Birengel S, Boşca A, Kurt H. Tekeli E. Sağlıklı bireylerde ve bazı hasta gruplarında lyme seropozitifliği. FLORA. 1999;4:51-7.
23
Çelik A, Turgut H, Çetin Ç, Yalçın A. Kaleli İ. Denizli yöresinde Borrelia burgdorferi antikor sıklığının araştırılması. İnfeksiyon Dergisi. 2001;15:439-41
24
Aydın K, Köksal İ, Çaylan R, Karagüzel A, Volkan S, Kaygusuz S, Öksüz R, Kostakoğlu U. Trabzon yöresinde lyme seropozitifliği. İnfek Derg 2001;15:141-4.
25
Demirci M, Yorgancıgil B, Tahan V, Arda M. Lyme disease seropositivity in people with history of tick bite in the Isparta region of Turkey. İnfek Derg. 2001;15.
26
Göral G, Kılıçturgay K, Aydın L. Antibody prevalence against Borrelia burgdorferi in some villages in the province of Bilecik. Turk J Med Sci. 1997;1997:51-3.
27
Hızel K, Ulutan F, Akta F. Lyme hastalığı ile uyumlu bulgusu olan hastalarda Borrelia burgdorferi antikorlarının araştırılması. İnfek Derg. 1997;11:87-91.
28
Mutlu G, Gültekin M, Ergin Ç, Sayın F, Kurşun AE. Antalya yöresinde Borrelia burgdorferi antikorlarının ve vektörlerinin araştırılması. Mikrobiyol Bult. 1995;29:1-6.
29
Utaş S, Kardaş Y, Doğanay M. Borrelia burgdorferi ile ilişkili olabilecek semptomları olan hasta grubunun Lyme serolojisi yönünden değerlendirilmesi. Mikrobiyol Bult. 1994;28:106-12.
30
Bucak O, Kocoglu ME, Tas T, Mengeloglu FZ. Evaluation of Borrelia burgdorferi sensu lato seroprevalence in the province of Bolu, Turkey. Turk J Med Sci. 2016;46:727-32.
31
Klinik Bakteriyoloji Tanı Standartları Çalışma Grubu (Türkiye Halk Sağlığı Kurumu). Lyme Hastalığının (Borrelia burgdorferi enfeksiyonunun) Mikrobiyolojik Tanısı [Internet]. 2015. Available from: http://mikrobiyoloji. thsk.saglik.gov.tr/Dosya/tani-rehberi/bakteriyoloji/UMS-B-MT-24-Lymehastaligi. pdf.
32
Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004;113:1093-101.
33
Rosa P. Lyme disease agent borrows a practical coat. Nat Med. 2005;11:831-2
34
Baranton G, De Martino SJ. Borrelia burgdorferi sensu lato diversity and its influence on pathogenicity in humans. Curr Probl Dermatol. 2009;37:1-17.
35
Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379:461-73
36
Feder HM, Jr., Abeles M, Bernstein M, Whitaker-Worth D, Grant-Kels JM. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. Clin Dermatol. 2006;24:509-20.
37
Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-134.
38
Meyerhoff JO, Zaidman GW, Steele RW. Lyme Disease: Medscape; 2015 [updated 21.01.2015; cited 2016 21.01.2016]. Available from: http:// emedicine.medscape.com/article/330178-overview.
39
Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007;297:2617-27.
40
Nigrovic LE, Thompson AD, Fine AM, Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area. Pediatrics. 2008;122:e1080-5.
41
Aiyer A, Hennrikus W, Walrath J, Groh B, Ostrov B. Lyme arthritis of the pediatric lower extremity in the setting of polyarticular disease. J Child Orthop. 2014;8:359-65.
42
Varela AS, Luttrell MP, Howerth EW, Moore VA, Davidson WR, Stallknecht DE, Little SE. First culture isolation of Borrelia ionestari, putative agent of southern tick-associated rash illness. J Clin Microbiol. 2004;42:1163-9.
43
Bransfield RC, Wulfman JS, Harvey WT, Usman AI. The association between tick-borne infections, Lyme borreliosis and autism spectrum disorders. Med Hypotheses. 2008;70:967-74.
44
Burbelo PD, Swedo SE, Thurm A, Bayat A, Levin AE, Marques A, Iadarola MJ. Lack of serum antibodies against Borrelia burgdorferi in children with autism. Clin Vaccine Immunol. 2013;20:1092-3.
45
Ajamian M, Kosofsky BE, Wormser GP, Rajadhyaksha AM, Alaedini A. Serologic markers of Lyme disease in children with autism. JAMA. 2013;309:1771-3.
46
Bransfield RC. The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms. Open Neurol J. 2012;6:88-93.
47
Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R. Lyme borreliosis in Europe. Euro Surveill. 2011;16.
48
CDC. Lyme Disease 2016. Available from: http://www.cdc.gov/lyme/ diagnosistesting/labtest/twostep/index.html.
49
European Union Concerted Action on Lyme Borreliosis 2016. Available from: http://www.eucalb.com/.
50
Linden H. Treatment of Lyme disease: Uptodate; 2016. Available from: http:// www.uptodate.com/contents/treatment-of-lyme-disease?source=search_ result&search=lyme+disease+treatment&selectedTitle=1~150.